InspireMD NSPR 2026 Earnings: First Quarter Review
Investors are zooming in on InspireMD after its Q1 2026 earnings. This detailed look breaks down the numbers, the pro...
Which Investors Should Avoid Robo Advisors outlines situations where automated options may underperform. This intro highlights alternatives to consider.
28,175 articlesInvestors are zooming in on InspireMD after its Q1 2026 earnings. This detailed look breaks down the numbers, the pro...
As biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...
Berkshire Hathaway’s massive cash pile has long frustrated investors. Now the company is finally putting some of that...
Plug Power stock popped after-hours following a strong Q4 showing and raised 2026 guidance. This article breaks down ...
June opened with volatility as Nu Holdings faced a fresh downgrade and a leadership transition. This article breaks d...
When a defense stock pops, investors want the quick answer: is this a one-off move or a real trend? This article brea...
The trillion-dollar club is crowded and growing. If micron makes trillion club, it could reshape memory stock bets an...
Joby Aviation has moved lower after hitting a peak. This guide weighs the risks and potential catalysts, and offers a...
Meta and Amazon are at the forefront of a trillion-dollar Big Tech capex surge, led by AI infrastructure and data-cen...
A Spain-focused ETF is delivering roughly a 50% one-year return, eclipsing EZU by a wide margin and signaling a sharp...
AMD signals a shift from pure CPUs to AI acceleration, blending edge and cloud compute. This article breaks down what...
Capricor's small-cap biotech story hinges on milestones, cash runway, and clinical progress. This guide breaks down w...